New Challenge in Rare Disease Drug Race
Despite a promising start, secukinumab's failure to treat Graves' orbitopathy leaves patients and pharmaceutical companies grappling with strategic setbacks.
Story Highlights
The ORBIT study found...
Breakthrough Drug Redefines Cancer Care
A new breakthrough in cancer treatment challenges the status quo, bringing hope and potential change to the standard of care.
Story Snapshot
Pirtobrutinib significantly improves...
Holiday Feast Could Trigger Heart Chaos
Your heart is more likely to short‑circuit between the turkey and the toast than on any random Tuesday—and the warning flares are hiding in...
Normal Blood Sugar Halves Heart Risk
A groundbreaking study reveals that simply achieving normal blood sugar levels can slash heart disease risk by half in prediabetic Americans.
Story Highlights
New research...
Infant Botulism Spreads: Retailers Delayed
The slow response of major retailers to remove recalled ByHeart infant formula is endangering children across the nation.
Story Highlights
Retailers failed to promptly remove...
The Secret Ingredient Beating Chronic Inflammation
The golden liquid sitting in your pantry might be the most scientifically validated weapon against chronic inflammation hiding in plain sight.
Story Highlights
Extra-virgin olive...
King Charles’s Cancer Battle: An Early Win
King Charles III’s revelation about reducing his cancer treatment due to early diagnosis brings to light the critical importance of early detection in cancer...
Fruit-Flavored Cocaine Targets Arizona Youth
Arizona parents are on high alert after the state's Attorney General issued a warning about fruit-flavored cocaine marketed to children, signaling a dangerous trend.
Story...
Virus Chaos Hits America’s Biggest Rodeo
A fast-moving equine virus is forcing America’s biggest rodeo to choose between cowboy tradition and strict biosecurity rules.
Story Highlights
EHV-1, a contagious equine virus...
Deadly Bat Virus Vaccine Enters Human Trials
A bat-borne virus with up to 75% fatality rate now advances to human trials.
Story Snapshot
Oxford's ChAdOx1 NipahB vaccine, built on the same platform...
